EmeraNova partners with Halo Biosystems for hyaluronic acid wound technology
EmeraNova has entered a commercialization collaboration involving Hyalomatrix, an established hyaluronic acid-based wound dressing, to expand access across hospitals, wound clinics and surgical settings. The arrangement adds another tissue restoration technology to its portfolio but does not represent a new FDA clearance or acquisition.